ClinicalTrials.gg
RecruitingNCT07691879Updated Nov 10, 2026

Preventive Potential of Fluoride Sealants in Adolescent Orthodontic Patients

An observational study in White Spot Lesions, sponsored by Sigmund Freud PrivatUniversitat. Recruiting at 1 site in Austria. Open to participants aged 10 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Sigmund Freud PrivatUniversitat · Observational

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Nov 10, 2026Now RecruitingFirst site in Austria+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
40
Ages
10 Years to 17 Years
Sex
All
01

Study summary

The aim of this trial is to investigate the potential of using an adhesive bonding agent that also acts as a fluoride sealant when placing fixed orthodontic appliances in adolescent patients, as an alternative to regular bonding agents.

The main question it aims to answer is:

- Does an adhesive fluoride sealant reduce the prevalence of white spot lesions in orthodontic adolescent patients after an observation period of 3 months?

Participants who need orthodontic treatment and who agree to take part in this study will have their orthodontic appliance placed using regular adhesive on one side of their upper jaw and fluoride sealant on the other.

White spot lesion prevalence will be assessed using the Enamel Decalcification Index (EDI) at baseline and after 3 months.

02

Conditions studied

  • White Spot Lesions
03

In context

Lead sponsor

Sigmund Freud PrivatUniversitat is the lead sponsor of 12 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Healthy adolscents who are in need of orthodontic treatment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 10 and 17 years
  • Initiation of fixed orthodontic treatment in the upper jaw
  • Presence of all teeth 15-25
  • Written consent from patients and legal guardians

Exclusion criteria

Exclusion Criteria

  • Pre-existing white spot lesions
  • Active carious lesions
  • Structural enamel defects
  • Systemic diseases affecting oral health
  • Vestibular restorations in the anterior region
  • Little Index > 9
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group Sealant

    Side of the maxilla in which a fluoride releasing bonding agent was used

    Other: Use of fluoride releasing bonding agent to place the orthodontic appliance

  • Control Group

    Side of the maxilla in which a regular bonding agent was used

    Other: Use of a bonding agent to place the orthodontic appliance

Interventions

  • OtherUse of a bonding agent to place the orthodontic appliance

    In this prospective study using the split-mouth design, patients will be followed for 3 months after placing the fixed orthodontic appliance. The orthodontic appliance will be placed according to the clinic's standards using an adhesive especially provided for this purpose.

  • OtherUse of fluoride releasing bonding agent to place the orthodontic appliance

    In this prospective study using the split-mouth design, patients will be followed for 3 months after placing the fixed orthodontic appliance. The orthodontic appliance will be placed according to the clinic's standards using an adhesive bondin agent that simultaneously works as a fluoride sealant especially provided for this purpose.

06

What researchers measure

Primary outcomes

  1. Prevalence of white spot lesions

    Time frame: 3 months

Secondary outcomes

  1. Enamel Decalcification Index (EDI)

    Difference in EDI between the groups

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Sigmund Freud Dental Clinic
    Vienna, 1020, Austria
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2026
First posted
Jul 9, 2026
StartActual
Sep 1, 2026
Primary completionEst.
Mar 1, 2027
CompletionEst.
May 1, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 10, 2026
Sites
1 site added — first site in Austria
Show site
  • Sigmund Freud Dental Clinic · Vienna, Austria
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Austria
    Show site
    • Sigmund Freud Dental Clinic · Vienna, Austria
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07691879
Lead sponsor
Sigmund Freud PrivatUniversitat
Responsible party
Sponsor
First posted
Jul 9, 2026
Start date
Sep 1, 2026
Primary completion
Mar 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Linda Schwarz, DMD, PhD
Contact
linda.schwarz@med.sfu.ac.at
+43 1 720 19 66
Michael H Bertl, Professor
study chair · Sigmund Freud Private University, Faculty of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion